The ROE (Return on Equity) of NGM Biopharmaceuticals Inc (NGM) is -95.79%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2023-12-31 | -95.79% |
| 2022-12-31 | -62.67% |
| 2021-12-31 | -35.85% |
| 2020-12-31 | -36.61% |
| 2019-12-31 | -12.94% |
| 2018-12-31 | -0.27% |
| 2017-12-31 | -8.17% |
| 2016-12-31 | -3.84% |